Beta Blocker News and Research

RSS
Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.
3D image of cell signaling molecules indicates a trippable power switch

3D image of cell signaling molecules indicates a trippable power switch

New data on safety of nitrous oxide as surgical anesthetic

New data on safety of nitrous oxide as surgical anesthetic

New review of medications to prevent migraines appears in Journal of General Internal Medicine

New review of medications to prevent migraines appears in Journal of General Internal Medicine

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

L-carnitine improves cardiac health in patients after heart attack, say researchers

L-carnitine improves cardiac health in patients after heart attack, say researchers

Researchers find association between melatonin, type 2 diabetes

Researchers find association between melatonin, type 2 diabetes

Study: Heart failure medications highly cost effective in saving lives

Study: Heart failure medications highly cost effective in saving lives

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

Trial evaluates ranolazine in patients with diabetes, coronary artery disease and angina

Trial evaluates ranolazine in patients with diabetes, coronary artery disease and angina

Research: Digoxin reduces hospital admission of older, acute heart failure patients

Research: Digoxin reduces hospital admission of older, acute heart failure patients

Aliskiren and standard therapy not associated with reduced CV death or HF rehospitalization

Aliskiren and standard therapy not associated with reduced CV death or HF rehospitalization

African-American women with breast cancer more likely to develop heart failure

African-American women with breast cancer more likely to develop heart failure

New Orleans residents continue to face increased risk of heart attack post-Katrina

New Orleans residents continue to face increased risk of heart attack post-Katrina

Morning, smooth ambulatory BP control ‘rarely achieved’ in general practice

Morning, smooth ambulatory BP control ‘rarely achieved’ in general practice

Arrhythmia may confound heart failure treatment

Arrhythmia may confound heart failure treatment

Scientists receive honorary doctorate for research on Alzheimer's disease

Scientists receive honorary doctorate for research on Alzheimer's disease

Being married and cohabiting reduces risk of heart attack in both men and women in all age groups

Being married and cohabiting reduces risk of heart attack in both men and women in all age groups

ADRB receptors play a direct role in Src activation by PKA-mediated mechanism

ADRB receptors play a direct role in Src activation by PKA-mediated mechanism

Controlling blood pressure and cholesterol may reduce risk of heart attack or stroke in diabetics

Controlling blood pressure and cholesterol may reduce risk of heart attack or stroke in diabetics

Emotional stress can reduce prostate cancer drugs’ effectiveness

Emotional stress can reduce prostate cancer drugs’ effectiveness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.